You are here: Home » Companies » News
Business Standard

Nomura's joint operations chief to be new CEO, Nagai to become chairman

The reshuffle was announced on Monday as Nomura posted its strongest quarterly profit in more than 17 years

Reuters  |  Tokyo 

File photo of the logo of Nomura Securities is seen at the company's Head Office in Tokyo, Japan. (Photo: Reuters)
File photo of the logo of Nomura Securities is seen at the company's Head Office in Tokyo, Japan. (Photo: Reuters)

has picked joint operations chief Kentaro Okuda to lead a turnaround of Japan's biggest brokerage and investment bank. He will take over from Chief Executive Koji Nagai, who will become chairman.

The reshuffle was announced on Monday as posted its strongest quarterly profit in more than 17 years. The brokerage is in cost-cutting mode after last year, recording its first annual loss in a decade.

With years of experience in investment banking, Okuda, 56, has also worked overseas, including as head of Nomura's US arm. He became a contender to succeed Nagai when he was promoted to joint chief operating officer in April 2018.

"can be stronger by taking good things from outside Japan. This is the area where I can show my originality," Okuda told a conference.

Okuda, who joined Nomura in 1987, will become CEO on April 1, 2020.

Nomura's reputation took a hit in May when it was censured by regulators after it was found to have leaked information related to listing and delisting criteria to clients.

That led the government to omit it as an underwriter in a Japan Post share sale and Nagai taking a 30 per cent pay cut for three months.

The incident came a month after Nomura reported an annual loss and said it would not pay bonuses to directors.

Nagai, 60, said on Monday that there was no direct connection between the management change and the scandal over leaked information.

"I have been working with Okuda on a business improvement plan after the information leak in May. I am not worried about him taking over because I know he can continue that effort," Nagai said.

Nagai is scheduled to speak to both foreign and domestic investors at an investment forum on Tuesday.

Sanofi to sell surgical product unit Seprafilm to Baxter for $350 mn

First Published: Mon, December 02 2019. 21:05 IST
RECOMMENDED FOR YOU